Gooch & Housego PLC – Interim Results

Gooch & Housego PLC – Interim Results

Gooch & Housego PLC (AIM:GHH), the specialist manufacturer of optical components and systems, today announces its interim results for the six months ended 31 March 2018.

Financial Highlights

Period ended 31 March

H1 2018

H1 2017

Change (%)

Revenue

£55.6m

£52.2m

6.6%

Adjusted profit before tax1

£7.0m

£6.2m

12.7%

Adjusted basic earnings per share 1

21.5p

18.7p

15.0%

Net cash

£5.0m

£7.8m

(35.1%)

Statutory profit before tax

£5.2m

£4.7m

11.6%

Statutory basic earnings per share

18.6p

14.1p

31.9%

Interim dividend per share

4.2p

3.7p

13.5%

1 Adjusted for amortisation of acquired intangible assets and non-recurring items.

Highlights

  • Strong revenue growth driven by microelectronic manufacturing and A&D sectors.
  • Revenue growth of 6.6% compared with the same period last year. Excluding the impact of foreign exchange, an increase of 14.0% over H1 last year.
  • Demand for high reliability fibre couplers lower than H1 last year, expected to come back in H2.
  • Continued investment in people, equipment and processes to drive further growth and take advantage of positive market conditions.
  • Adjusted profit growth of 12.7% compared with same period last year.
  • Record half year order book of £84.7 million, as at 31 March 2018, an increase of 27.1% compared with the same period last year. Excluding the impact of foreign exchange, an increase of 36.4%.
  • Interim dividend increased to 4.2p (2017:3.7p).

Mark Webster, Chief Executive Officer of Gooch & Housego, commented:

 “Overall market conditions remain good, we have a record half year order book and expectations for full year trading remain in line with management’s expectations.

“The introduction of a new manufacturing organisation has enabled us to more readily upgrade capacity and performance, in particular at our Ilminster and Fremont, CA sites, in order to meet the unprecedented demand in the microelectronic sector.

“G&H remains committed to our strategy of diversification and moving up the value chain. We have an active policy of building a diverse and balanced business by establishing a ‘critical mass’ in life sciences and further strengthening our position in A&D, through investing in a mix of R&D and acquisitions. A&D now represents about a third of our business. We believe this means G&H is well positioned for future growth.”

No Comments

Post a Comment